These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 19309351

  • 1. Opposite effect of fluticasone and salmeterol on fibronectin and tenascin-C expression in primary human lung fibroblasts.
    Degen M, Goulet S, Ferralli J, Roth M, Tamm M, Chiquet-Ehrismann R.
    Clin Exp Allergy; 2009 May; 39(5):688-99. PubMed ID: 19309351
    [Abstract] [Full Text] [Related]

  • 2. Lung myofibroblasts as targets of salmeterol and fluticasone propionate: inhibition of alpha-SMA and NF-kappaB.
    Baouz S, Giron-Michel J, Azzarone B, Giuliani M, Cagnoni F, Olsson S, Testi R, Gabbiani G, Canonica GW.
    Int Immunol; 2005 Nov; 17(11):1473-81. PubMed ID: 16210331
    [Abstract] [Full Text] [Related]

  • 3. Opposite effect of corticosteroids and long-acting beta(2)-agonists on serum- and TGF-beta(1)-induced extracellular matrix deposition by primary human lung fibroblasts.
    Goulet S, Bihl MP, Gambazzi F, Tamm M, Roth M.
    J Cell Physiol; 2007 Jan; 210(1):167-76. PubMed ID: 17013807
    [Abstract] [Full Text] [Related]

  • 4. Effect of interleukin 13 on bronchial hyperresponsiveness and the bronchoprotective effect of beta-adrenergic bronchodilators and corticosteroids.
    Townley RG, Gendapodi PR, Qutna N, Evans J, Romero FA, Abel P.
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):190-7. PubMed ID: 19354064
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Changes in lung function and health status in patients with COPD treated with tiotropium or salmeterol plus fluticasone.
    Kurashima K, Hara K, Yoneda K, Kanauchi T, Kagiyama N, Tokunaga D, Takayanagi N, Ubukata M, Sugita Y.
    Respirology; 2009 Mar; 14(2):239-44. PubMed ID: 19210650
    [Abstract] [Full Text] [Related]

  • 9. Effect of combining salmeterol and fluticasone on the progression of airway remodeling.
    Vanacker NJ, Palmans E, Pauwels RA, Kips JC.
    Am J Respir Crit Care Med; 2002 Oct 15; 166(8):1128-34. PubMed ID: 12379559
    [Abstract] [Full Text] [Related]

  • 10. Anti-proliferative and anti-remodelling effect of beclomethasone dipropionate, formoterol and salbutamol alone or in combination in primary human bronchial fibroblasts.
    Descalzi D, Folli C, Nicolini G, Riccio AM, Gamalero C, Scordamaglia F, Canonica GW.
    Allergy; 2008 Apr 15; 63(4):432-7. PubMed ID: 18076728
    [Abstract] [Full Text] [Related]

  • 11. [Inhaled corticosteroids in patients with COPD: maintain current guidelines].
    Heijdra YF.
    Ned Tijdschr Geneeskd; 2007 Oct 06; 151(40):2195-7. PubMed ID: 17969568
    [Abstract] [Full Text] [Related]

  • 12. Tiotropium and salmeterol/fluticasone combination do not cause oxygen desaturation in COPD.
    Andò F, Ruggeri P, Girbino G, Cazzola M.
    Respir Med; 2008 Jun 06; 102(6):815-8. PubMed ID: 18343646
    [Abstract] [Full Text] [Related]

  • 13. Ultrastructural features of lung fibroblast differentiation into myofibroblasts.
    Kaarteenaho-Wiik R, Paakko P, Sormunen R.
    Ultrastruct Pathol; 2009 Jun 06; 33(1):6-15. PubMed ID: 19191196
    [Abstract] [Full Text] [Related]

  • 14. Pro- and anti-inflammatory factors cooperate to control hyaluronan synthesis in lung fibroblasts.
    Wilkinson TS, Potter-Perigo S, Tsoi C, Altman LC, Wight TN.
    Am J Respir Cell Mol Biol; 2004 Jul 06; 31(1):92-9. PubMed ID: 14764429
    [Abstract] [Full Text] [Related]

  • 15. Heterogeneous response of nasal and lung fibroblasts to transforming growth factor-beta 1.
    Nonaka M, Pawankar R, Fukumoto A, Yagi T.
    Clin Exp Allergy; 2008 May 06; 38(5):812-21. PubMed ID: 18355371
    [Abstract] [Full Text] [Related]

  • 16. Fluticasone and ibuprofen do not add to the effect of salmeterol on organic dust-induced airway inflammation and bronchial hyper-responsiveness.
    Strandberg K, Ek A, Palmberg L, Larsson K.
    J Intern Med; 2008 Jul 06; 264(1):83-94. PubMed ID: 18298484
    [Abstract] [Full Text] [Related]

  • 17. mRNA expression and protein distribution of fibronectin splice variants and high-molecular weight tenascin-C in different phases of human fracture healing.
    Kilian O, Dahse R, Alt V, Zardi L, Hentschel J, Schnettler R, Kosmehl H.
    Calcif Tissue Int; 2008 Aug 06; 83(2):101-11. PubMed ID: 18663401
    [Abstract] [Full Text] [Related]

  • 18. Fluticasone, but not salmeterol, reduces cigarette smoke-induced production of interleukin-8 in human airway smooth muscle.
    Oltmanns U, Walters M, Sukkar M, Xie S, Issa R, Mitchell J, Johnson M, Chung KF.
    Pulm Pharmacol Ther; 2008 Aug 06; 21(2):292-7. PubMed ID: 17692547
    [Abstract] [Full Text] [Related]

  • 19. Management of chronic obstructive pulmonary disease: moving beyond the asthma algorithm.
    Gordon E, Lazarus SC.
    J Allergy Clin Immunol; 2009 Nov 06; 124(5):873-80; quiz 881-2. PubMed ID: 19895979
    [Abstract] [Full Text] [Related]

  • 20. Association between CRHR1 polymorphism and improved lung function in response to inhaled corticosteroid in patients with COPD.
    Kim WJ, Sheen SS, Kim TH, Huh JW, Lee JH, Kim EK, Lee JH, Lee SM, Lee S, Lim SY, Shin TR, Yoon HI, Oh YM, Lee SD.
    Respirology; 2009 Mar 06; 14(2):260-3. PubMed ID: 19210659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.